News Press Releases Identifying Promising Precision Immunotherapy Approaches For Advanced Prostate Cancer Gathering New Insights into Advanced Prostate Cancer Immunotherapies Awarded the 2021 V Foundation Translational Research Award for the project titled, "Investigating the Therapeutic Potential for STING Agonists to Overcome Resistance to Immune Checkpoint Blockade in PTEN-deficient Prostate Cancer” Presentation - Unveiling the Role of Rb Gene in Prostate Cancer: BET Inhibitors and Immunotherapy Selected for the 2022 Michael & Lori Milken Family Foundation-PCF Challenge Award to develop novel immunotherapy approaches in advanced prostate cancer Promising Personalized Targeted Immunotherapy Combination Treatment Identified For an Aggressive Form of Advanced Prostate Cancer Presentation - Elucidating Mechanisms of Resistance to ADT/PI3K-AKT Blockade in PTEN-Deficient mCRPC Stronger together: A successful combination to treat advanced prostate cancer PARP inhibitor becomes new treatment option for some men with advanced prostate cancer An unexpected success for cancer immunotherapy treating prostate cancer Ivanhoe Broadcast News: Checkmate for Prostate Cancer Prostate Cancer Foundation Announces New Recipients of 2016 PCF Challenge Awards to Promote Research in Deadly Prostate Cancer By boosting innate immunity, researchers eradicate aggressive prostate cancer in mice Patnaik Highlights Evolution Toward Immunotherapy in Prostate Cancer Enhancing immunotherapies in prostate cancer: A Q&A with Dr. Akash Patnaik Pathways to Discovery: Meet the Expert Ongoing Clinical Trials Recent Grants and Awards
